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Genetic Ablation of PARP-1 Protects Against
Oxazolone-Induced Contact Hypersensitivity
by Modulating Oxidative Stress
Attila Brunya´nszki1, Csaba Hegedu+s1,2, Magdolna Sza´nto´1, Katalin Erde´lyi1,2, Katalin Kova´cs1,
Vale´rie Schreiber3, Szabolcs Gergely4, Borba´la Kiss5, E´va Szabo´5, La´szlo´ Vira´g1,2 and Pe´ter Bai1,2
Contact hypersensitivity (CHS) reaction is a form of delayed-type of hypersensitivity caused by contact allergens
such as oxazolone (OXA). In previous studies it has been shown that poly(ADP-ribose) polymerase (PARP)
inhibition reduces the extent of inflammation in CHS. We aimed to shed light on the molecular events causing
the protective effect of PARP inhibitors. PARP-1 and -2 knockout mice were sensitized by abdominal delivery
of OXA, and a week later CHS was induced by applying OXA on the ears of the mice. PARP-1/ mice were
protected against OXA-induced CHS in contrast to PARP-2/ mice. In PARP-1/ mice, neutrophil infiltration
was reduced in line with the suppressed expression of proinflammatory cytokines, cell adhesion factors,
and matrix metalloproteinase-9, which is likely because of impaired activation of NF-kB p65 and activating
transcription factor-2, the two redox-sensitive transcription factors. Moreover, reduced nitrosative and oxidative
stress was observed under inflammatory conditions in the PARP-1/ mice when compared with PARP-1þ /þ .
In conclusion, PARP-1 activation is necessary for proinflammatory gene expression through which PARP-1
enhances neutrophil infiltration and hence oxidative/nitrosative stress, forming a vicious circle, and further
aggravating the inflammatory process. Our data identify PARP-1 as a possible target in CHS.
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INTRODUCTION
The poly(ADP-ribose) polymerase (PARP) superfamily con-
sists of 17 members, with some of them implicated in the
regulation of the immune response. PARP-1 and PARP-2
belong to the subgroup that can be activated in vivo by DNA
single-strand breaks or in vitro by DNase I-treated DNA or
aberrant DNA forms (de Murcia and Menissier-de Murcia,
1994; Ame et al., 1999). Because of its abundance and high
catalytic activity, PARP-1 is responsible for most of the
cellular PARP activity after DNA damage (Shieh et al., 1998).
PARP-1 activation results in the cleavage of NADþ substrate
and the synthesis and attachment of poly(ADP-ribose) (PAR)
polymers to different acceptor proteins (Schraufstatter et al.,
1986; Schreiber et al., 2006).
Both PARP-1 and PARP-2 have been described to
influence inflammatory processes through modulating nu-
merous transcription factors (Hassa and Hottiger, 2008;
Yelamos et al., 2008). PARP-1 interacts with a large number
of proinflammatory transcription factors, and the beneficial
effects of PARP-1 ablation on inflammatory damage have
been shown in multiple disease models such as colitis,
arthritis, uveitis, and pancreatitis (Virag and Szabo, 2002).
Recent data suggest that PARP-2 may also affect immune
functions. PARP-2/ mice suffer compromised thymopoesis
that leads to impaired survival of CD4þ CD8þ double-
positive thymocytes and consequently to weaker systemic
T-cell functions (Yelamos et al., 2006). In addition, PARP-2
associates with transcription factors (such as thyroid tran-
scription factor-1 and peroxisome proliferator activated
receptor-g) and with protein factors influencing the histone
code, pointing toward a plethora of possible alterations in
gene expression (Bai et al., 2007; Quenet et al., 2008;
Yelamos et al., 2008).
Contact hypersensitivity (CHS) is a form of T cell-mediated
delayed type of hypersensitivity reaction caused by small-
molecular-weight molecules (haptens) that bind to host
proteins to form a complete allergen (Grabbe and Schwarz,
1998). The CHS reaction can be divided into the sensitization
and elicitation phase. In the elicitation phase, proinflamma-
tory cytokines and chemokines recruit different inflammatory
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Infiltration is accompanied by oxidative stress due to the
formation of superoxide, hydrogen peroxide, nitric oxide, per-
oxynitrite, and further reactive species (Morita et al., 1996;
Rowe et al., 1997; Olmos et al., 2007; Korkina and Pastore,
2009), leading to DNA breakage and PARP activation (Szabo
et al., 2001). Recently, we showed that the inhibition of PARP
activation has beneficial effects during the CHS reaction (Bai
et al., 2009). In this study we set out to identify the PARP
isoform mediating CHS and to characterize the molecular
events during the elicitation phase of the CHS reaction.
RESULTS AND DISCUSSION
PARP-1/, but not PARP-2/, mice are protected against
OXA challenge
We evaluated the ear swelling, as a measure of inflammatory
edema, 24 hours after oxazolone (OXA) challenge. OXA
challenge in wild-type (WT) mice caused a 4- to 5-fold ear
swelling compared with vehicle-sensitized animals, whereas
ear swelling was significantly reduced in the PARP-1/
mice. In contrast, there was no significant difference between
the OXA-sensitized PARP-2þ /þ and the OXA-sensitized
PARP-2/ mice (Figure 1a).
The myeloperoxidase (MPO) activity, indicative of the
neutrophil infiltration, showed similar changes to ear swel-
ling. PARP-1/, but not PARP-2/, mice were protected
against the OXA-evoked increase in MPO activity (Figure 1b).
The degree of protection provided by the PARP-1/
phenotype was similar to the one previously observed in
mice treated with the PARP inhibitor, PJ34 (Bai et al., 2009).
PARP-1/, but not PARP-2/, mice are protected against
the irritative component of CHS
In addition to the antigen-specific reaction, an irritative compo-
nent is usually also present in contact allergies (Grabbe et al.,
1996). Therefore, we applied a 12-O-tetradecanoyl-phorbol
13-acetate-induced irritative dermatitis model (Bai et al., 2009)
to investigate whether the antigen-specific and/or the nonspecific
irritant response is affected by PARP-1 and -2. Similar to our
previous observations with the PARP inhibitor compound
PJ34 (Bai et al., 2009), the PARP-1/ phenotype also con-
ferred partial protection against the 12-O-tetradecanoyl-phorbol
13-acetate-induced irritative dermatitis, both at the level of ear
swelling and MPO activity (Figure 2a and b). In contrast, genetic
ablation of PARP-2 did not affect irritative dermatitis. We
detected marked cellular infiltration upon 12-O-tetradecanoyl-
phorbol 13-acetate induction (Figure 2d), in line with strong
induction of matrix metalloproteinase (MMP) activity that was
reduced in PARP-1/ mice (Figure 2c). As our data indicate
that PARP-2 has no functional role in CHS or in irritative
dermatitis, we focused our mechanistic investigation on the role
of PARP-1 and omitted the PARP-2 knockout strain from all
further studies.
Genetic ablation of PARP-1 suppresses inflammatory cell
immigration in CHS reaction
Histology examination revealed a marked infiltration of the
ear with inflammatory cells upon OXA challenge that was
reduced in the PARP-1/ mice (Figure 3a). This is in good
correlation with ear swelling and MPO activity as presented
in Figure 1.
CHS is characterized by a mixed infiltration of poly-
morphonuclear leukocytes, monocytes (Olmos et al., 2007),
and T cells. Staining for cell type-specific markers revealed
predominant neutrophil infiltration in the connective tissue.
In line with the suppressed inflammatory response, neutrophil
infiltration was markedly reduced in the PARP-1/ mice
(Figure 3b).
We went on to investigate the expression of proinflamma-
tory cytokines and chemokines. On the course of the allergic
inflammation, we observed the induction of macrophage
inflammatory protein-1a and-2, IL-1b, tumor necrosis factor-a,
and monocyte chemotactic protein-1. A reduced expression
of all of these cytokines/chemokines has been observed in
the PARP-1/ mice (Figure 4a). These chemokines/cytokines
are known mediators of CHS (Saint-Mezard et al., 2004;
Olmos et al., 2007) and are of different origin (dermal
cells, mast cells, or Langerhans cells) possessing pleiotropic
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Figure 1. PARP-1/, but not PARP-2/, mice are protected against the
oxazolone-induced CHS reaction. (a) Ear thickness was measured before
and 24 hours after challenge by a caliper, and ear swelling was expressed
as the difference of the two values. (b) At 24 hours after OXA challenge,
ears were removed and relative MPO activity was determined. *Po0.05;
***Po0.001, significant difference between cohorts. CHS, contact hypersensitivity;
MPO, myeloperoxidase; OXA, oxazolone; PARP, poly(ADP-ribose)
polymerase.
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effects (Biedermann et al., 2000) leading to the (1) upregula-
tion of cellular adhesion molecules on the surface of
the endothelium (McHale et al., 1999a, b); and (2) the
recruitment, activation, and proliferation of inflammatory
cells (Homey et al., 1998; Lim et al., 2008), culminating in
inflammation.
As cellular extravasation and infiltration under inflamma-
tory conditions require the concerted expression of different
cell adhesion molecules such as I-CAM, L-CAM, V-CAM, and
E-selectin (Fuchs et al., 2001; Kelly et al., 2007), we
examined their expression. As expected, OXA challenge
induced I-CAM, L-CAM, V-Cam, and E-selectin expression in
the WT mice that was absent in the PARP-1/ mice (Figure
4b). Similar observations have previously been made in
several oxidative stress-related pathologies, in which inhibi-
tion or genetic ablation of PARP-1 reduced the expression of
these adhesion molecules, leading to decreased inflammatory
infiltration (Zingarelli et al., 1999). Importantly, there is a
strong correlation between the expression of the above-
mentioned chemokines/cytokines (e.g., monocyte chemotac-
tic protein-1 and tumor necrosis factor-a) and cellular
adhesion molecules as all rely on NF-kB activation (Oliver
et al., 1999; Virag and Szabo, 2002; Haddad et al., 2006;
Espinoza et al., 2007).
In addition to adhesion molecules, leukocytes also secrete
MMPs to facilitate their movements in tissues. MMPs are
expressed as zymogens that are subsequently activated either
by proteolytic cleavage or free radical-induced structural
changes (Le et al., 2007). We have observed the induction of
MMP-9 upon OXA challenge in the PARP-1þ /þ mice.
However, MMP-9 induction was impaired in the PARP-1/
mice (Figure 4c). Our observation is in line with other models
of inflammation, in which MMP-9 expression was found to
be reduced on pharmacological PARP inhibition or by
treatment with small interfering RNA against PARP-1
(Kauppinen and Swanson, 2005; Koh et al., 2005). MMP
activity is controlled by tissue inhibitors of metalloproteinases
1–4. Interestingly, tissue inhibitor of metalloproteinase-2 was
downregulated in PARP-1þ /þ mice, which may explain
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Figure 2. PARP-1/, but not PARP-2/, mice are protected against the PMA-induced irritative dermatitis. PMA (10ml, 0.05% w/v) was smeared
onto both sides of the ears of female mice (six animals per group). After 24 hours, (a) ear swelling, (b) MPO, and (d) MMP activities were determined.
(c) Formalin-fixed, paraffin-embedded tissue sections were stained with HE. Scale bar¼ 200mm. HE, hematoxylin and eosin; MMP, matrix metalloproteinase;
MPO, myeloperoxidase; PARP, poly(ADP-ribose) polymerase; PMA, 12-O-tetradecanoyl-phorbol 13-acetate.
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Figure 3. Genetic ablation of poly(ADP-ribose) polymerase-1 (PARP-1)
suppresses inflammatory cell immigration. Formalin-fixed, paraffin-embedded
tissue sections were stained with (a) hematoxylin and eosin (HE) and, (b) for
neutrophil elastase, with 4,6-diamidino-2-phenylindole (DAPI) counterstain.
The arrows point at the neutrophil elastase-positive cells (linear contrast adjustment
was applied on image b). Scale bars¼ 200mm for a and 20mm for b.
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MMP-9 activation (Figure 4c). On the contrary, its expression
was not reduced in PARP-1/ mice. It is noteworthy that
pharmacological PARP inhibition has previously also been
found to prevent downregulation of this tissue inhibitor
(Oumouna-Benachour et al., 2007; Bai et al., 2009).
PARP-1 interacts with a plethora of transcription factors
and modulates their activity, and hence gene expression.
Therefore, we hypothesized that the absence of PARP-1
protein and the consequent loss of PARP-1 activity may be
the underlying mechanism for the altered expression of
inflammatory mediators. We assessed the activation of a
number of transcription factor in the ears. We have observed
the strong activation of two redox-sensitive transcription
factors, p65, a member of the NF-kB family and activating
transcription factor-2 (ATF-2), on OXA sensitization in the
PARP-1þ /þ mice (Figure 4d). Interestingly, the activation of
other members of the REL family, p50 and c-Rel, was not
detectable. The activation of p65 was completely absent in
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Figure 4. Expression of proinflammatory genes is suppressed in the PARP-1/ mice. Expression of (a) a set of proinflammatory cytokines, (b) adhesion
molecules, (c) MMP-9 and TIMP-2 were determined with qRT-PCR. (d) Transcription factor activation was determined using the TransFactor kit. *Po0.05;
***Po0.001, significant difference between cohorts. ATF-2, activating transcription factor-2; MCP-1, monocyte chemotactic protein-1; MIP, macrophage
inflammatory protein; MMP, matrix metalloproteinase; PARP, poly(ADP-ribose) polymerase; qRT-PCR, quantitative real-time reverse transcriptase-PCR; TIMP-2,
tissue inhibitor of metalloproteinase-2; TNF-a, tumor necrosis factor-a.
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the PARP-1/ mice. ATF-2 showed a similar pattern to p65,
although its activity was only partially reduced in the
knockout mice (Figure 4d).
The defective p65 activation is in line with the reduced
expression of numerous NF-kB target genes such as inducible
nitric oxide synthase (iNOS), adhesion factors, and cytokines
(Haddad et al., 2006; Espinoza et al., 2007). The direct
molecular interaction between PARP-1 and NF-kB has
already been described (Hassa and Hottiger, 1999; Oliver
et al., 1999). ATF-2 is a cAMP-responsive element-binding
transcription factor that forms complex with c-Jun or itself
and binds to activator protein-1 sites (Reimold et al., 2001).
ATF-2 has been shown to be regulated by PARP-1 (Ha, 2004).
Genetic deletion of ATF-2 leads to impaired activator protein-
1 activation and consequently to reduced expression of
cytokines (tumor necrosis factor-a, IFN-g, IL-1, IL-6, or
monocyte chemotactic protein-1a) and adhesion factors
(E-selectin and P-selectin) (Reimold et al., 2001). Deficient
activator protein-1 activation upon PARP-1 ablation
has already been described in a murine model of colitis
providing a protective phenotype (Zingarelli et al., 2004).
Apparently, the combined effects of PARP knockout on
ATF-2 and NF-kB may culminate in the changes described
in this study.
The lack of oxidative/nitrosative stress in the PARP-1/ mice
Leukocytic infiltration is usually accompanied by the
production of reactive oxygen and nitrogen species, such as
hydrogen peroxide and peroxynitrite, a reactive nitrogen
species, formed in the reaction of nitric oxide and superoxide
(Beckman and Koppenol, 1996).
In the ear, the endothelial NOS (eNOS) and iNOS
enzymes can be considered as the most important sources
of nitric oxide under inflammatory conditions; therefore, we
assessed their expression. Although eNOS expression was lower
in the PARP-1/ mice when compared with PARP-1þ /þ ,
it did not change upon OXA challenge (Figure 5a). Therefore,
eNOS cannot be considered as the major source of nitric
oxide under inflammatory conditions. Similar to eNOS, iNOS
expression was lower in the PARP-1/ animals than in
PARP-1þ /þ mice under normal conditions. Importantly,
iNOS expression increased markedly upon OXA challenge,
whereas only mild induction was observed in the OXA-
treated PARP-1/ mice (Figure 5a). Apparently, iNOS seems
to be the major source of nitric oxide in our model system.
This is in line with other findings obtained in different models
of inflammation (Virag and Szabo, 2002).
Nitrosative stress is indicated by the formation of protein
tyrosine nitration that could be observed in the ears of WT but
not PARP-1/ mice (Figure 5b). Nitrotyrosine staining could
be detected in the infiltrating cells and in the keratinocytes,
with strongest immunopositivity observed in the microabs-
cesses, in which widespread keratinocyte death has
previously been described (Ormerod et al., 1997; Szabo
et al., 2001; Cals-Grierson and Ormerod, 2004; Olmos et al.,
2007).
We assessed the level of oxidative stress that generally
accompanies nitrosative stress. We detected increased lipid,
protein, and DNA base oxidation (as shown by protein
carbonylation, protein-4-hydroxy-2-nonenal adduct, and
8-OHdG formation) that was all reduced in the PARP-1/
mice (Figure 6a–c).
Oxidative and nitrosative stress can induce DNA breakage
and PARP activation (Virag and Szabo, 2002; Hassa and
Hottiger, 2008). Therefore, we set out to investigate DNA
strand breakage by TUNEL assay. DNA strand breaks
appeared in keratinocytes, endothelial cells, and leukocytes
(Figure 6d) in PARP-1þ /þ mice. There was a high number of
TUNEL-positive cells in the microabscesses, suggesting
intense oxidative stress (Figure 6d). The number of TUNEL-
positive cells was reduced in the PARP-1/ subjects. DNA
strand breaks led to PARP-1 activation, resulting in the
formation of PAR (Virag and Szabo, 2002; Hassa and
Hottiger, 2008). A nuclear PAR signal could be detected in
the PARP-1þ /þ mice that was absent in the PARP-1/ animals
(Figure 6e). PAR was present in all cell types in the ear.
Our data show that PARP-1 is a regulator of inflam-
mation in CHS; however, other members of the PARP
family (except for PARP-2) might also be implicated.
The group of macroPARPs (PARP-9/Bal1, PARP-14/Bal2,
and PARP-15/Bal3) also possess immunological roles
(reviewed in Hakme et al., 2008), suggesting that their
involvement cannot be excluded in cutaneous inflammatory
processes. However, PAR glycohydrolase, which is respon-
sible for PAR degradation, is a more likely candidate for
regulating CHS. Despite the opposing biochemical role,
PAR glycohydrolase often shares similar transcriptional
function with PARP-1 (Frizzell et al., 2009) and it affects
inflammatory gene expression (Rapizzi et al., 2004). Tannins
are inhibitors of PAR glycohydrolase (Ying and Swanson,
2000), and it is tempting to hypothesize that the effectiveness
of the commonly used tannin-containing external products
in dermatology may be related to their PAR glycohydrolase
inhibitory effects.
These data obtained in PARP-1/ mice are very similar to
previous results obtained with the administration of a PARP
inhibitor compound in the elicitation phase of CHS (Bai et al.,
2009). It is important to note the important difference
between pharmacological PARP inhibition and PARP-1
knockout. On one hand, the pharmacological inhibitor
causes general PARP inhibition affecting all PARP isoforms,
and on the other, application of pharmacological inhibitor
after the sensitization phase allows us to determine the
enzymes’ role on the elicitation phase. In the knockout study,
however, the absence of PARP-1 may affect both the
sensitization and the elicitation phase. For example, uptake
and presentation of antigens by dendritic cells is a
cornerstone of efficient sensitization. As both ATF-2 and
NF-kB have important roles in dendritic cell function (Stepnik
and Arkusz, 2003; Sasaki and Aiba, 2007), it cannot be
excluded that the sensitization phase of CHS is also impaired
in the PARP-1/ mice. This possibility, however, would
require further investigation.
In the effector phase, PARP-1 modulates several key steps
of inflammation such as: (1) cellular infiltration, (2) expression
of chemokines, (3) adhesion molecules, (4) MMPs, and (5) the
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redox-sensitive p65 and ATF-2 transcription factors. In a
possible scenario, the increasing level of oxidative/
nitrosative stress enhances PARP-1 activation that in turn
boosts all the previously described processes, further
aggravating oxidative/nitrosative stress and creating a vicious
circle. In fact, PARP-1 has a central role in the control of
oxidative stress in the elicitation phase of CHS, and its
inhibition or genetic deletion disrupts the self-intensifying
propagation of inflammation. Altogether, these results pro-
vide further support for the possible therapeutic applicability
of PARP inhibitors in CHS.
MATERIALS AND METHODS
Materials
OXA and all chemicals were from Sigma-Aldrich (St Louis, MO)
unless stated otherwise.
Animal studies
All animal experiments were approved by the local ethical
committee (9/2008/DE MA´B) and were performed according to the
European Union and national guidelines. Homozygous female
PARP-1 and PARP-2 knockout mice and their respective WT
littermates on C57/Bl6 background were used (Menissier-de Murcia
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Figure 5. Reduced nitrosative stress in poly(ADP-ribose) polymerase (PARP)-1/ mice. (a) Inducible and endothelial nitric oxide synthase (iNOS and eNOS)
expression was determined by quantitative real-time reverse transcriptase PCR (qRT-PCR). (b) Nitrotyrosine immunohistochemistry was performed on
formalin-fixed, paraffin-embedded tissue sections. NS, nonsensitized. *Po0,05; ***Po0.001, significant difference between cohorts (linear contrast adjustment
was applied on image b). Scale bar¼ 20mm.
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et al., 1997; Menissier-de Murcia et al., 2003). CHS model was
performed as described in Szabo et al. (2001), and irritative
dermatitis model was performed as described in Bai et al. (2009).
Histology and microscopy
Hematoxylin–eosin staining and immunohistochemistry was performed
on paraffin-fixed 7mm tissue sections as described in Szabo et al. (2001).
MPO activity measurement
The measurement of MPO activity has been described in Virag et al.
(2004).
MMP activity measurement
Ear homogenates were incubated with fluorescein-labeled gelatin
(Invitrogen, Carlsbad, CA) and then fluorescein fluorescence was
determined and normalized for protein content.
Characterization of oxidative stress
Commercial kits from Cell Biolabs (Sand Diego, CA) were used for
determining 8-OHdG and 4-hydroxy-2-nonenal. Protein carbonyla-
tion was determined using a commercial kit from Cayman
Chemicals (Ann Harbor, MI). Samples were processed according
to the manufacturer’s instructions.
mRNA preparation and reverse transcription and quantitative PCR
Total RNA preparation, and reverse transcription and quantitative
PCR were performed as described in Bai et al. (2007). Normalized
expression values were expressed as fold increase compared with
samples from WT nonsensitized mice. Primers are summarized in
Supplementary Table S1 online.
Transcription factor transactivation studies
For nuclear protein extraction, the TransFactor Extraction kit
(Clontech, Mountain View, CA), and for transactivation studies,
TransFactor Inflammatory Profiling-1 kit (Clontech) were used
according to the manufacturer’s instructions. The results are
expressed as fold increase compared to WT non-sensitized samples.
Statistical analysis
Results were expressed as means±SEM. Statistical significance
between groups was determined using Student’s t-test, and Po0.05
was considered as significant. Error bars represent±SEM.
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